Skip to main content
Clinical Trials/NCT03424785
NCT03424785
Completed
Not Applicable

Long Term Follow-up and Clinical Implications in Chinese Patients With Aortic Intramural Hematoma

Shenyang Northern Hospital0 sites270 target enrollmentJune 3, 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic Intramural Hematoma
Sponsor
Shenyang Northern Hospital
Enrollment
270
Primary Endpoint
hematoma thickness and a baseline MAD
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The study evaluates outcomes of intramural hematomas after long-term follow up and establish predictive factors in Chinese population.

Detailed Description

270 intramural hematoma patients with clinical and imaging follow up were retrospectively studied in present study. The primary endpoint was consisted of aortic disease-related death, aortic dissection, penetrating atherosclerotic aortic ulcer , thickening of aorta hematoma and aortic complications requiring surgical or endovascular treatment.

Registry
clinicaltrials.gov
Start Date
June 3, 2008
End Date
May 14, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Shenyang Northern Hospital
Responsible Party
Principal Investigator
Principal Investigator

Han Yaling, MD

Long term follow-up and clinical implications in Chinese patients with aortic intramural hematoma

Shenyang Northern Hospital

Eligibility Criteria

Inclusion Criteria

  • Type A aortic hematoma
  • Type B aortic hematoma

Exclusion Criteria

  • Aortic without initial intimal flap formation.

Outcomes

Primary Outcomes

hematoma thickness and a baseline MAD

Time Frame: 14years

Medication and short-term imaging are recommended for Chinese IMH patients with a hematoma thickness less than 10.45 mm and a baseline MAD less than 44.75 mm. Rigorous medical observation should also be performed during the acute phase of IMH.

Similar Trials